Abbott Laboratories (ABT) Accounts Payables (2009 - 2026)
Abbott Laboratories (ABT) posted Accounts Payables of $4.8 billion for Q2 2026, up 2.46% sequentially from $4.7 billion in Q1 2026, and up 11.33% YoY from $4.3 billion in Q2 2025.
Abbott Laboratories (ABT) Accounts Payables (2009 - 2026) Analysis & Trends
Abbott Laboratories has reported Accounts Payables for 18 years, with the latest figure at $4.8 billion in Q2 2026.
- Quarterly Accounts Payables rose 11.33% year-over-year to $4.8 billion in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $4.8 billion (up 11.33% YoY) and the FY2025 annual result came in at $4.2 billion, up 1.07% from the prior year.
- Accounts Payables rose to $4.8 billion in Q2 2026 per ABT's latest filing, from $4.7 billion in the prior quarter.
- Over five years, Accounts Payables peaked at $4.8 billion in Q2 2026 and troughed at $4.0 billion in Q3 2023.
- A 5-year average of $4.3 billion and a median of $4.2 billion in 2023 frame the typical range for Accounts Payables.
- The sharpest annual moves came in 2022 and 2023: Accounts Payables advanced 16.99% in 2022, then slipped 12.4% in 2023.
- Over 5 years, Accounts Payables stood at $4.6 billion in 2022, then declined by 6.77% to $4.3 billion in 2023, then dropped by 2.33% to $4.2 billion in 2024, then increased by 1.07% to $4.2 billion in 2025, then increased by 13.07% to $4.8 billion in 2026.
- According to Business Quant data, Accounts Payables over the past three periods registered $4.8 billion, $4.7 billion, and $4.2 billion for Q2 2026, Q1 2026, and Q4 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn | 4.79 Bn |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn | 1.66 Bn |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn | 2.64 Bn |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn | 1.23 Bn |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn | 210.50 Mn |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn | 3.23 Bn |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn | 2.42 Bn |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn | 344.10 Mn |
| 10 | Zimmer Biomet Holdings | 19.42 Bn | 19.01 Bn | 1.54 Bn | 352.40 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 4.79 Bn |
| Mar 31, 2026 | 4.68 Bn |
| Dec 31, 2025 | 4.24 Bn |
| Sep 30, 2025 | 4.12 Bn |
| Jun 30, 2025 | 4.31 Bn |
| Mar 31, 2025 | 4.21 Bn |
| Dec 31, 2024 | 4.20 Bn |
| Sep 30, 2024 | 4.03 Bn |
| Jun 30, 2024 | 4.13 Bn |
| Mar 31, 2024 | 4.18 Bn |
| Dec 31, 2023 | 4.30 Bn |
| Sep 30, 2023 | 3.96 Bn |
| Jun 30, 2023 | 4.21 Bn |
| Mar 31, 2023 | 4.17 Bn |
| Dec 31, 2022 | 4.61 Bn |
| Sep 30, 2022 | 4.13 Bn |
| Jun 30, 2022 | 4.49 Bn |
| Mar 31, 2022 | 4.76 Bn |
| Dec 31, 2021 | 4.41 Bn |
| Sep 30, 2021 | 4.02 Bn |